To: bentway who wrote (780598 ) 4/19/2014 2:36:52 AM From: i-node Respond to of 1582685 >> I don't think patients in the US should carry the cost of developing new drugs, no. You do? I do. Because no one else can. We are the wealthiest society in the world. If we are unable or unwilling to pay for developing new drugs, they simply won't be developed and everyone loses. The best approach is to allow OUR markets to decide what they will and won't pay for, because markets, even fucked up ones, are better than government price controls. >> If the companies weren't making money in those other countries, they wouldn't SELL there, would they? But they ARE. Which means we're chumps. You don't understand the basics of microeconomics. That's like saying that Microsoft wouldn't sell Windows at a discount in other countries. If the market in Africa is $5/copy for Windows, why in hell wouldn't they sell it for that? It is better than getting nothing. This is a very fundamental concept in both microeconomics and managerial accounting. Profits are maximized where the marginal cost of producing a unit is equal to the marginal revenue of producing it. You want to operate as close to that point as possible. In accounting terms, as long as incremental revenue >= incremental cost, you'll sell the item. If we are to do anything at all about it, the approach should be the US negotiating with other countries which are positioned to adjust their price controls to higher levels. We give them something they want to increase what they'll pay for a given drug, and get a commitment out of drug manufacturers to hold their margins constant. Allowing drug reimportation is generally the wrong approach, as it provides a perverse incentive for the foreign reseller.